Sartorius AG, established in 1870 and based in Göttingen, Germany, operates globally as a key provider of sophisticated bioprocess solutions, laboratory products, and specialized services. The company's extensive product line encompasses advanced biosensors, compliance tools, system software, and both label-free detection and SPR systems. It also offers comprehensive live-cell analysis platforms, flow cytometry equipment, and a wide array of cell analysis reagents and consumables. Sartorius is a major supplier of specialized cell culture media for diverse applications, including antibody production, viral vaccines, and regenerative medicine, along with general media, downstream buffers, microcarriers, stem cell reagents, strong acids, bases, alcohols, and detergents. Its portfolio further includes a complete range of bioreactor systems—multi-parallel, benchtop, single-use, stainless steel, cell culture, and microbial—all supported by dedicated software applications. A strong focus on filtration technology provides membranes, blotting products, various filter papers, glass and quartz microfibre products, and an extensive selection of filtration and ultrafiltration devices for sterile processes, harvesting, analytical and diagnostic sample preparation, buffer exchange, particle analysis, and pharmaceutical filtration, in addition to syringe filters and membrane chromatography products. Sartorius also delivers solutions for process filtration, process chromatography, fluid management, and integrates process analytical technology with data analytics. Complementary offerings include industrial microbiology systems, water purification units, precision weighing and pipetting systems, OEM solutions, and centrifuges. Beyond products, the company offers vital services in bioprocess development and engineering, protein expression systems, media and process optimization, testing, instrument support, and validation. These integrated solutions cater to a diverse clientele within life science research, biopharmaceutical manufacturing, quality control and testing, and various applied industrial sectors worldwide.
The current price of SARTF is $217.65 USD — it has increased by +0% in the past 24 hours. Watch Sartorius stock price performance more closely on the chart.
What is Sartorius stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sartorius stocks are traded under the ticker SARTF.
What is Sartorius market cap?▼
Today Sartorius has the market capitalization of 7.45B
When is the next Sartorius earnings date?▼
Sartorius is going to release the next earnings report on July 23, 2026.
What were Sartorius earnings last quarter?▼
SARTF earnings for the last quarter are 1.39 USD per share, whereas the estimation was 1.48 USD resulting in a -6.53% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sartorius revenue for the last year?▼
Sartorius revenue for the last year amounts to 8.23B USD.
What is Sartorius net income for the last year?▼
SARTF net income for the last year is 298.81M USD.
Does Sartorius pay dividends?▼
Yes, SARTF dividends are paid annual. The last dividend per share was 0.84 USD. As of today, Dividend Yield (FWD)% is 0.38%.
How many employees does Sartorius have?▼
As of June 16, 2026, the company has 13,573 employees.
In which sector is Sartorius located?▼
Sartorius operates in the Health & Wellness sector.
When did Sartorius complete a stock split?▼
The last stock split for Sartorius was on June 13, 2016 with a ratio of 4:1.
Where is Sartorius headquartered?▼
Sartorius is headquartered in Göttingen, United States.